SCHEMBL7903531

SCHEMBL7903531

CC(=O)Nc1ccc2c(c1)CCNC2

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.56
PLG P00747 1/20 0.56
PLAU P00749 1/20 0.56
PLAT P00750 1/20 0.56
KLKB1 P03952 1/20 0.56
PRSS1 P07477 1/20 0.56
MELK Q14680 2/20 0.56
SLC2A1 P11166 2/20 0.51
CYP1A2 P05177 1/20 0.50
ADRA2A P08913 1/20 0.50
MAOA P21397 1/20 0.50
SLC6A2 P23975 1/20 0.50
HTR2C P28335 1/20 0.50
SLC6A4 P31645 1/20 0.50
HTR2B P41595 1/20 0.50
ITGB3 P05106 1/20 0.50
ITGA2B P08514 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
BAZ2B Q9UIF8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31174279 0.98 F2 (0.55) F2PLGPLAUPLATKLKB1
SCHEMBL3891388 0.94 MELK (0.63) F2PLGPLAUPLATKLKB1
SCHEMBL31174281 0.94 MELK (0.63) F2PLGPLAUPLATKLKB1
SCHEMBL4591764 0.90 MELK (0.61) MELKSLC2A1CYP1A2ADRA2AMAOA
SCHEMBL531907 0.87 CYP1A2 (0.55) CYP1A2ADRA2AMAOASLC6A2HTR2C
SCHEMBL3658561 0.86 F2 (0.57) F2PLGPLAUPLATKLKB1
Hydrochloric Acid SCHEMBL4761772 0.85 ITGB3 (0.55) CYP1A2ADRA2AMAOASLC6A2HTR2C
SCHEMBL3003689 0.85 F2 (0.54) F2PLGPLAUPLATKLKB1
Hydrochloric Acid SCHEMBL18491400 0.84 ITGB3 (0.56) F2PLGPLAUPLATKLKB1
SCHEMBL8474350 0.84 F2 (0.50) F2PLGPLAUPLATKLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373634-B1 MORPHOLINONE COMPOUNDS AS FACTOR IXA INHIBITORS MOCHIDA PHARM CO LTD (JP) 2015-11-11 EP disclosed
US-20110135650-A1 MORPHOLINONE COMPOUNDS AS FACTOR IXA INHIBITORS MERCK SHARP & DOHME LLC 2011-06-09 US disclosed
WO-2010065717-A1 MORPHOLINONE COMPOUNDS AS FACTOR IXA INHIBITORS MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110135650-A1 MORPHOLINONE COMPOUNDS AS FACTOR IXA INHIBITORS SERPINC1, F9, F8 F2 14/4885PLG 48/4885PLAU 57/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.